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Mouse Vα14-Jα18 and human Vα24-Jα18 
NKT cells are innate-like, CD1d-restricted, 
autoreactive lymphocytes that regulate several 
infectious, autoimmune, and cancerous con-
ditions (1). Their TCR structure combines a 
canonical TCR α chain with TCR β chains 
that belong to a restricted set of Vβ families in-
cluding Vβ8, Vβ7, Vβ2 in mice and Vβ11 in 
humans (2). Unlike the invariant TCR α chain, 
these TCR β chains exhibit a wide diversity 
of CDR3 junctions (3–5), nearly all of which 
allow for the recognition of the self-glycosphin-
golipid iGb3 (6), the microbial cell wall α-glyc-
uronosylceramides (7, 8), and their mimic 
α-GalCer. In addition, a fraction of NKT cells 
was reported to recognize mycobacterial phos-
phatidylinositolmannosides (9).
The mechanisms leading to the striking Vβ 
bias during development and the consequences 
on microbial ligand recognition have remained 
unexplained. For example, it is unclear whether 
the Vβ bias refl  ects pairing preferences with the 
invariant TCR α chain or the predominant 
  infl  uence of positive selection or negative selec-
tion during thymic development. There are 
reports of pairing defects of the invariant TCR 
α chain with a Vβ11 chain in vitro (10) and 
with Vβ chains lacking the solvent-exposed Cβ 
FG loop in vitro and in vivo (11), suggesting 
that many Vα14-Jα18/Vβ dimers are unstable. 
In addition, diff  erent contributions of individ-
ual Vβ8, Vβ7, and Vβ2 families to the affi   nity 
of recognition of α-GalCer have been shown 
(12), suggesting that the Vβ bias may also re-
fl  ect thymic selection by lipid ligands. Indeed, 
recent studies suggested Vβ-specifi  c diff  erences 
in avidity for CD1d/endogenous ligand, namely 
a higher avidity of Vβ7 chains (13, 14). How-
ever, because these studies did not examine the 
recognition properties of the nonbiased Vβ 
repertoire before selection by CD1d/ligands, 
the forces shaping the Vβ bias during thymic 
development have not been explored.
Here, we have created a population of mature 
Vα14-Jα18 T cells expressing a diverse, nonbi-
ased Vβ repertoire by expressing a Vα14-Jα18 
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Mouse and human natural killer T (NKT) cells recognize a restricted set of glycosphingolipids 
presented by CD1d molecules, including self iGb3 and microbial 𝗂-glycuronosylcera  mides. 
The importance of the canonical V𝗂14-J𝗂18 TCR 𝗂 chain for antigen recognition 
by NKT cells is well recognized, but the mechanisms underlying the V𝗃8, V𝗃7, and V𝗃2 
bias in mouse have not been explored. To study the infl  uences of thymic selection and the 
constraints of pairing with V𝗂14-J𝗂18, we have created a population of mature T cells 
expressing V𝗂14-J𝗂18 TCR 𝗂 chain in CD1d-defi  cient mice and studied its recognition 
properties in vitro and in vivo. Transgenic cells expressed a diverse V𝗃 repertoire but their 
recognition of endogenous ligands and synthetic iGb3 was restricted to the same biased V𝗃 
repertoire as expressed in natural NKT cells. In contrast, 𝗂-GalCer, a synthetic homologue 
of microbial 𝗂-glycuronosylceramides, was recognized by a broader set of V𝗃 chains, in-
cluding the biased NKT set but also V𝗃6, V𝗃9, V𝗃10, and V𝗃14. These surprising fi  ndings 
demonstrate that, whereas V𝗃8, V𝗃7, and V𝗃2 represent the optimal solution for recogni-
tion of endogenous ligand, many V𝗃 chains that are potentially useful for the recognition 
of foreign lipids fail to be selected in the NKT cell repertoire.
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TCR α transgene in CD1d-defi  cient (CD1d−/−) mice. Our 
studies demonstrate that the invariant TCR α chain could 
pair indiscriminately with the entire Vβ repertoire, ruling 
out pairing biases as a substantial factor. Second, we found 
that only Vβ7, Vβ8, and Vβ2 allowed for recognition of en-
dogenous ligand and iGb3, with a Vβ7>Vβ8>Vβ2 hierar-
chy of responses paralleling the corresponding Vβ enrichment 
by thymic selection in vivo, demonstrating a predominant 
role of positive selection over negative selection in shaping 
the Vβ repertoire. In contrast, many Vβ families that are not 
represented in the natural NKT cell repertoire were never-
theless capable of recognition of foreign and microbial lipids, 
revealing a surprisingly ineffi     cient selection of potentially 
useful TCRs.
RESULTS
V𝗂14-J𝗂18 transgenic (Tg) cells in CD1d−/− mice
Vα14-Jα18 TCR α chain Tg mice have an increased popu-
lation of canonical CD44highNK1.1+ NKT cells with the ex-
pected Vβ8, Vβ7, Vβ2 bias and CD4 or double negative 
(DN) phenotype. We previously reported that some Tg lines 
also harbored in their thymus and spleen a peculiar subset of 
mature T cells with a CD44low/intNK1.1− DN phenotype 
and a conspicuous absence of Vβ bias (15). By crossing the 
Vα14-Jα18 transgene onto a CD1d−/− background, we 
found that the canonical NK1.1+ NKT cells had disappeared, 
as expected, whereas the CD44low/intNK1.1− DN T cells per-
sisted (Fig. 1, top and middle). Most of the CD44low/int NK1.1− 
DN T cells lacked endogenous Vα chains because only 2% 
were stained by a combination of antibodies against Vα2, 
Vα3.2, Vα8, and Vα11, which otherwise accounted for 
26% of the TCR α chains expressed by other T cells (Fig. 1, 
bottom). Thus, it is likely that the DN T cells express the in-
variant Vα14-Jα18 TCR α chain encoded by the transgene, 
whereas other T cells express endogenous Vαs. Consistent 
with the expression of Vα14-Jα18, up to 25% of the DN T 
cells were brightly stained by the α-GalCer-CD1d tetramers 
(Fig. 1, bottom). Such a peculiar DN lineage maturing in the 
absence of thymic ligand has been described previously in 
many TCR Tg systems and is believed to be induced by the 
early expression of the Tg TCR α chain at the DN3 stage 
(as we observed in this Tg line; unpublished data) competing 
with the pre-TCR α chain for signaling (16–20). Impor-
tantly, these Tg cells were reported to respond to their ligand 
in a dosage-dependent manner despite the absence of thymic 
selection (21).
Nonbiased V𝗃 repertoire of V𝗂14-J𝗂18 Tg DN cells 
in CD1d−/− mice
We next studied the Vβ repertoire associated with the invari-
ant TCR α chain in the Vα14-Jα18 Tg DN T cells of 
CD1d−/− mice. For comparison with another nonselected 
Vβ repertoire, we used CD4+CD8+ double positive (DP) 
thymocytes from β2m−/−.I-Ab−/− “MHC-null” mice that 
express high levels of surface TCR readily stained by anti-Vβ 
antibodies (22). For comparison with the CD1d-restricted 
repertoire, we used CD3+NK1.1+ thymocytes from WT B6 
mice thymuses, which contain >95% canonical tetramer+ 
NKT cells (23). Fig. 2 shows that, in dramatic contrast with 
the biased Vβ8, Vβ7, Vβ2 repertoire of natural NKT cells in 
WT mice, the CD1d−/− Tg DN cells expressed a very di-
verse repertoire. This repertoire appeared relatively close to 
the nonselected DP thymocytes in MHC-null mice, although 
signifi  cant diff  erences were found for some Vβs suggesting 
that, in the absence of selection by CD1d, Vα14-Jα18 im-
parts only modest pairing bias compared with the average Vα 
Figure 1.  Mature DN T cells in V𝗂14tg.CD1d−/− mice. 
(top) The spleen of Vα14tg mice harbors a sizeable population of 
CD4−CD8α−CD3ε+ DN T cells (boxed in gate b) that is independent of 
CD1d expression. (middle) Gated DN T cells have a uniform CD44low/intNK1.1− 
phenotype in Vα14tg.CD1d−/− mice. (bottom) The DN T cells of Vα14tg.
CD1d−/− mice do not express endogenous TCR α chains; 25% of them are 
α-GalCer-CD1d tetramer+. Note that, in contrast, the CD4 and CD8 T cells 
(boxed in gate a) in these mice express endogenous Vαs but are α-GalCer-
CD1d tetramer-negative. Data are representative of four independent 
experiments with two mice per group.JEM VOL. 203, May 15, 2006  1199
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chain. To further evaluate the diversity of the Vβ repertoire 
associated with Vα14-Jα18, we cloned and sequenced mul-
tiple CDR3 segments generated by RT-PCR from sorted, 
CD1d−/− Tg DN cells. We chose three TCR β chains, 
Vβ8.2, Vβ8.1, and Vβ12, as representatives of Vβs highly, 
poorly, or nonenriched in natural NKT lineage cells, respec-
tively. Fig. 3 shows a broad distribution of CDR3 lengths 
and a broad usage of Jβ segments for each of these TCR β 
chains, with a similar overrepresentation of the Jβ2 over the 
Jβ1 cluster as previously reported for conventional T cells 
(24, 25). We found 77–94% of unique sequences in each set 
of TCR β chains analyzed, similar to previous fi  ndings 
  reported for other T cell populations (26, 27). Together, 
these results establish the broad diversity of the Vβ repertoire 
expressed by the CD1d−/− Tg DN cells. Thus, pairing of 
Vα14-Jα18 with TCR β chains is largely promiscuous and 
unlikely to be a signifi  cant factor in the Vβ repertoire bias 
of Vα14 NKT cells. Furthermore, comparison of the non-
selected Vβ repertoire of CD1d−/− Tg DN cells with the 
natural Vβ repertoire of mature NKT thymocytes allowed a 
precise calculation of the degree of enrichment associated 
with thymic selection for each Vβ family. Thus, Vβ2 was 
enriched 2.6-fold, Vβ8.2 was enriched 8-fold, and Vβ7 was 
enriched 12-fold. A similar percentage of Vβ7 and Vβ8.1+8.2 
as in the CD1d−/− Tg DN cells was also found in DP thymo-
cytes obtained from another CD1d−/− Vα14-Jα18 TCR Tg 
strain where the transgene was driven by a CD4 promoter to 
avoid premature expression at the DN3 stage (unpublished 
data). Thus, this striking Vβ7>Vβ8.2>Vβ2 hierarchy con-
trasts with previous estimates derived merely from the rela-
tive frequency of Vβs expressed by NKT cells, where 
Vβ8.2>Vβ7 because it was six times more frequent than 
Vβ7. It also diff  ers signifi  cantly from estimates derived by 
comparing the NKT lineage repertoire with mainstream DP 
thymocytes where Vβ7 “enrichment” was similar to that of 
Vβ8.2 (14).
V𝗃-specifi  c binding of 𝗂-GalCer-CD1d tetramers
α-GalCer-CD1d tetramers stain nearly all mouse NKT cells 
expressing Vα14-Jα18 combined with Vβ8, Vβ7, Vβ2 (23, 28). 
In the nonselected Vα14-Jα18 Tg DN T cells, 69–85% of 
cells expressing Vβ8, Vβ7, and Vβ2 were tetramer+ (Fig. 4), 
indicating that these Vβs are usually, though not always, 
compatible with α-GalCer recognition independently of the 
CDR3 sequence. Surprisingly, however, 36–84% of cells ex-
pressing additional Vβ families that are not signifi  cantly rep-
resented in the natural NKT cell repertoire (Fig. 2), including 
Vβ3, 6, 9, 10, and 14, were also stained by the tetramers. 
Figure 2.  V𝗃 repertoire of V𝗂14tg.CD1d−/− DN T cells. The Vβ 
repertoires of splenic CD3ε+ DN T cells in Vα14tg.CD1d−/− mice, DP thy-
mocytes in MHC-null mice, and CD3ε+NK1.1+ thymic NKT cells in 
C57BL/6 mice are compared. Histograms show staining by a panel of anti-
Vβ mAbs with percentages as indicated. Data are means ± SD of three 
independent experiments with at least two mice per group.1200  Vβ CONTRIBUTION TO GLYCOLIPID RECOGNITION BY NKT CELLS | Wei et al.
Other Vβs, such as Vβ4, 5, 11, 12, and 13 were mostly neg-
ative, although they consistently included 3–10% positive 
cells. Thus, these results reveal many new Vβ families that 
  allow for α-GalCer recognition but had escaped prior recog-
nition because of their absence from the natural NKT cell 
repertoire. As expected, an extended Vβ repertoire was also 
found for the microbial lipid α-glucuronylceramide of which 
α-GalCer is a mimic (unpublished data).
V𝗃-specifi  c induction of CD69 by CD1d/lipid ligands
Because iGb3-CD1d tetramers could not stain NKT cells (6), 
we devised T cell stimulation assays to compare the Vβ rep-
ertoires specifi  c for iGb3 and α-GalCer. Thymocytes have 
very poor endocytic properties and are therefore defective in 
the presentation of exogenous lipid ligands requiring endo-
somal access for processing or loading onto CD1 molecules 
(reference 29 and unpublished data). Therefore, we used 
DCs pulsed with antigen to stimulate DN T cells obtained 
from the spleen of Vα14tg.CD1d−/− mice. After 4–6 h, DN 
T cells were harvested and stained for CD69. Fig. 5 shows 
that a large fraction of Vβ2, 7, and 8 cells up-regulated CD69 
in response to DCs pulsed with either iGb3 (20–46%) or α-
GalCer (56–77%) when compared with unpulsed DCs from 
CD1d−/− mice (3–4%). Consistent with the tetramer staining 
experiments, many additional Vβs were stimulated by α-
GalCer, including Vβ3, 6, 9, 10, 14 (23–63%), whereas others 
(Vβ4, 5, 11, 12, 13) gave very weak responses (4–12%). In-
terestingly, when compared with CD1d−/− DCs, unpulsed 
WT DCs weakly but consistently stimulated Vβ2, 7, and 8 
cells (14–33%), suggesting that natural ligand expression was 
suffi   cient to induce CD69 on a subset of cells expressing the 
Vβ families naturally associated with NKT cells. Thus, in 
contrast with α-GalCer, both the natural ligands expressed 
by DCs and exogenously added synthetic iGb3 elicited the 
Figure 3.  V𝗂14tg.CD1d−/− DN T cells have diverse CDR3 se-
quences. Vβ8.1- (n = 35), Vβ8.2- (n = 58), and Vβ12-CDR3 (n = 96) 
sequences amplifi  ed by RT-PCR from sorted Vα14tg.CD1d−/− DN T cells 
were cloned and sequenced. (A) Bar graphs of CDR3 lengths (a.a., amino 
acid). (B) Frequencies of Jβ usage expressed as percentage of total 
  sequences. Note that a similar bias in Jβ2 cluster usage has been reported 
for conventional T cells. (C) Number of unique and duplicate sequences 
among Vβ8.1, Vβ8.2, and Vβ12.
Figure 4.  V𝗃-specifi  c binding of 𝗂-GalCer-CD1d tetramers to 
V𝗂14tg.CD1d−/− DN T cells. Freshly isolated splenocytes from 
Vα14tg.CD1d−/− mice were stained with α-GalCer-CD1d tetramer, CD3ε, 
CD4 and CD8α, and a panel of anti-Vβ mAbs. Dot plots are gated on 
CD3ε+CD4−CD8α− cells. Numbers in the top right quadrants indicate 
the percentages of tetramer+ cells among the Vβ positive cells. Data 
are mean ± SD from three individual mice analyzed in three 
independent experiments.JEM VOL. 203, May 15, 2006  1201
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very same Vβ repertoire as expressed by natural NKT cells. 
Importantly, neither synthetic iGb3 nor naturally expressed 
ligands stimulated other Vβs, suggesting that the Vβ bias of 
natural NKT cells must refl  ect positive selection of these Vβs 
rather than negative selection of other Vβs.
V𝗃-specifi  c induction of cell division by CD1d/lipid ligands
Although CD69 can be induced by partial TCR signaling, 
T cell proliferation requires stronger “agonist” signals (30). 
Indeed, iGb3 was reported to be an agonist ligand for mouse 
and human NKT cells and a prime candidate for mediating 
the positive selection and the expansion of NKT cell precur-
sors in the thymus (6). Therefore, to model the expansion of 
selective Vβs during NKT development, we used CFSE-
  labeled DN T cells to compare the mitogenic properties of 
endogenous and exogenous NKT ligands in a cell culture 
system. IL-7 was added to prevent the death of unstimulated 
cells over the 4-d culture period with antigen-pulsed DCs. 
When DN T cells were incubated with CD1d−/− DCs alone, 
a background CFSE dilution of  50%, likely the result 
of IL-7, was observed for all Vβs in diff  erent experiments. 
Remarkably, CD1d-expressing WT DCs induced a signifi  -
cant and selective expansion of Vβ7 cells (84%) in the ab-
sence of added ligands, above the background CFSE dilution 
observed in Vβ6 and Vβ12 cells (45–48%) (Fig. 6). Vβ2 
(57%) and Vβ8 (62%) were slightly higher than Vβ6 and 
Vβ12. These data suggest that naturally expressed ligands can 
act as true albeit weak agonists capable of inducing cell 
  proliferation, with the highest affi   nity for Vβ7, similar to the 
Vβ7>Vβ8>Vβ2 hierarchy observed in the CD69 induction 
Figure 5.  V𝗃-specifi  c expression of CD69 by antigen-
  stimulated V𝗂14tg.CD1d−/− DN T cells. Enriched DN T cells from 
Vα14tg.CD1d−/− spleens were cocultured with CD1d−/− DCs or WT DCs 
pulsed with 100 ng/ml iGb3, 1 ng/ml α-GalCer, or no antigen. 
T cells were stimulated for 4 h with α-GalCer or for 6 h with iGb3. 
  Percentages of CD69-positive DN T cells gated according to Vβ usage 
are indicated in top right quadrants as mean ± SD from four 
independent experiments.1202  Vβ CONTRIBUTION TO GLYCOLIPID RECOGNITION BY NKT CELLS | Wei et al.
assay (compare with Fig. 5). When a low dose of anti-CD3ε 
antibody was used to induce polyclonal activation, all Vβs 
underwent similar expansion, demonstrating that the selec-
tive Vβ response to naturally expressed NKT ligands was 
specifi  c to these antigens. DCs pulsed with synthetic iGb3 
induced the selective expansion of Vβ2, 7, and 8 cells (89–
96%) well above the levels induced by naturally expressed 
ligands but with a similar Vβ7>Vβ8>Vβ2 hierarchy. In 
contrast, consistent with the experiments using tetramer 
staining (Fig. 4) and short-term induction of CD69 (Fig. 5), 
α-GalCer induced a strong expansion not only of Vβ2, 7, 
and 8 cells (98–99%) but also Vβ6 cells (95%), whereas Vβ12 
cells remained close to background, as expected from their 
lack of CD69 induction.
V𝗃-specifi  c hierarchy in responses to glycolipid ligands
To extend the aforementioned fi  ndings to the larger Vβ rep-
ertoire and to more rigorously quantitate the apparent diff  er-
ences in individual Vβ responses, DCs were pulsed with a 
range of concentrations of α-GalCer and iGb3 before cocul-
ture with CFSE-labeled DN T cells. Fig. 7 shows the CFSE 
dilution profi  les according to Vβ expression, with statistics dis-
played whenever dilution was >50% background level. Fre-
quencies of CFSE-negative (>7 divisions) and CFSE-low cells 
were displayed separately to provide a quantitation of 
the rate of proliferation in addition to the frequency of cells 
having proliferated. Furthermore, absolute cell recoveries 
  according to Vβ expression were also recorded (Table I). 
α-GalCer expanded a broad range of Vβ, including Vβ2, 6, 7, 
8.2, 9, 10, and 14. These results closely resembled the patterns 
found with tetramer staining (Fig. 4) and CD69 induction 
(Fig. 5). However, one notable exception was Vβ3, which 
stained with tetramers (36%) and induced CD69 (23%), yet 
failed to induce detectable expansion. Closer   examination of 
Figs. 4 and 5 indicated that the fl  uorescence intensity of stain-
ing with tetramers or CD69 was clearly lower for Vβ3 than 
for other responder Vβs, suggesting lower affi   nity as an expla-
nation for the lack of proliferation. Vβ7 and Vβ8.2 cells had 
comparable responses over a range of α-GalCer concentra-
tions, as judged by the percentage of cells that diluted CFSE to 
low or negative levels and by the cellular expansion measured 
in absolute cell numbers (Table I). Slight diff  erences between 
Vβ7 and Vβ8.1+8.2 cells were the result of the heterogeneity 
of Vβ8 because Vβ8.1 was much less responsive than Vβ8.2 to 
α-GalCer (Fig. 6 and Table I). In a previous report (12), stain-
ing of Vβ8.2 NKT cells with a dimeric CD1d-αGalCer ligand 
(CD1d-IgG1) was somewhat brighter than that of Vβ7. This 
apparent discrepancy with our results may refl  ect diff  erences 
between the pre- and postselection NKT cell repertoire or, al-
ternatively, indicate that the affi   nity estimated by ligand stain-
ing does not always correlate well with various forms of 
functional stimulation. In contrast with Vβ8.2 and Vβ7, Vβ2 
cells were  10 times less responsive to α-GalCer than either 
Vβ7 or Vβ8 cells, as judged by the 10 times greater amount of 
α-GalCer required for Vβ2 cells to achieve similar CFSE dilu-
tions as Vβ8.2 and Vβ7 cells. The other responder Vβ chains, 
  including Vβ6, 9, 10, and 14, required concentrations of α-
GalCer in the ng/ml range for cell expansion, somewhat higher 
than Vβ2, though still in the low range compared with peptide 
antigens of conventional MHC-restricted T cells.
Stimulation by iGb3 demonstrated remarkably distinct 
  features (Fig. 7). In general, iGb3 exerted its stimulatory eff  ects 
at concentrations 30–50 times greater than those needed for 
α-GalCer, but it is unclear at present whether this diff  erence 
in potency refl  ects a lower affi   nity (weak agonist) or diff  erent 
requirement for uptake and presentation by DCs. In contrast 
with α-GalCer and as noted in the CD69 induction assay in 
Fig. 5, iGb3 nearly exclusively stimulated Vβ2, Vβ7, and Vβ8, 
Figure 6.  V𝗃-specifi  c proliferation of antigen-stimulated V𝗂14tg.
CD1d−/− DN T cells. CFSE-labeled Vα14tg.CD1d−/− DN T cells were co-
cultured with antigen-pulsed DCs in the presence of 10 ng/ml IL-7 for 
4 d and CFSE dilution profi  les were gated according to Vβ expression. DCs 
were pulsed with no antigen, iGb3 at 50 ng/ml or α-GalCer at 10 ng/ml. 
Control stimulation was with a low dose of 50 ng/ml of anti-CD3ε 
  directly added to the culture wells. Data are representative of three 
 independent  experiments.
Table I.  Vβ-specifi  c expansion of Vα14tg.CD1d−/− DN T cells 
stimulated by lipid antigens
𝗂-GalCer (ng/ml) iGb3 (ng/ml)
0.01 0.1 1 10 0.5 5 50 500
Vβ2 0.6 0.9 4.2 9.2 0.5 0.7 3.7 4.3
Vβ6 ND ND 1.7 2.7 ND ND <0.5 <0.5
Vβ7 2.1 4.0 15.6 27.3 1.4 3.0 10.2 14.6
Vβ8.1 + 8.2 1.2 1.9 8.7 17.3 0.6 1.2 5.1 6.8
Vβ8.2 1.5 2.6 12.0 23.1 0.7 1.3 6.0 7.2
Vβ9N D N D <0.5 4.7 ND ND <0.5 <0.5
Vβ10 ND ND <0.5 4.1 ND ND <0.5 <0.5
Vβ14 ND ND 3.2 9.4 ND ND <0.5 <0.5
non-Vβ2, 7, & 8 ND ND 0.6 0.7
The fold increase in the absolute number of cells expressing indicated Vβs at the 
end of a 4-d culture period is shown for a range of concentrations of α-GalCer and 
iGb3. Data are representative of four independent experiments. ND, not determined.JEM VOL. 203, May 15, 2006  1203
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thus faithfully mimicking the natural NKT cell bias. This highly 
selective eff  ect was further illustrated by the near background 
CFSE dilution (57%) found for all the non-Vβ2, 7, 8 cells ex-
amined together at the highest concentration of iGb3 (Fig. 7, 
bottom right). Furthermore, iGb3 was 10 times more stimula-
tory for Vβ7 than for Vβ8.2 cells, as judged by the proportion 
of cells reaching the CFSE-negative stage and by the cell ex-
pansion measured in absolute numbers (Table I). For example, 
40% of Vβ7 cells had reached the CFSE-negative stage at 0.5 
ng/ml of iGb3 compared with only 34% of Vβ8.2 at 5 ng/ml 
(Fig. 7), and the level of expansion of Vβ7 at 0.5 ng/ml was 
not reached until 5 ng/ml for Vβ8.2 (Table I). Thus, the data 
establish a clear hierarchy of Vβ stimulation by iGb3, with 
Vβ7>Vβ8.2>Vβ2, fully consistent with their respective 12-, 
8-, and 2.6-fold enrichments during thymic selection (Fig. 2). 
This good correlation between the hierarchy measured in vitro 
and the selection bias in vivo is consistent with iGb3 being a 
major thymic ligand for NKT precursors and further suggests 
that positive selection rather than negative selection plays the 
primary role in shaping the Vβ repertoire of Vα14 NKT cells.
Correlations between V𝗃 selection and CD1d levels in vivo
Previous reports have shown that changes in Vβ selection 
occurred in mice expressing lower or higher levels of CD1d, 
Figure 7.  V𝗃-specifi  c hierarchy of responses to graded con-
centrations of antigens. CFSE-labeled Vα14tg.CD1d−/− DN T cells 
were stimulated as in Fig. 6 using a range of antigen concentrations. 
Numbers in each histogram indicate the percentage of cells within the 
corresponding brackets of CFSE-negative (left) and CFSE-low (right) 
cells. Histograms with no percentages have <50% CFSE-diluted cells. 
Data are representative of four inde  pendent experiments.1204  Vβ CONTRIBUTION TO GLYCOLIPID RECOGNITION BY NKT CELLS | Wei et al.
and were hypothesized to result from changes in positive and 
negative selection according to Vβ affi   nities for naturally ex-
pressed ligands. Thus, in mice expressing very high levels of 
CD1d ( 50 times greater than WT) under a MHC class I 
promoter (13), NKT cells were decreased in absolute num-
bers to 1/3 of WT, suggesting negative selection, with Vβ2 
NKT cells being relatively overrepresented compared with 
Vβ8 and Vβ7 cells. Conversely, Vβ7 were overrepresented 
in BALB/c.CD1d+/− mice as compared with WT (14). Al-
though the intricacies of positive and negative selection and 
clonal competition preclude a defi   nitive interpretation of 
such results when considered alone, the data are fully consis-
tent with the hierarchy of Vβ responsiveness to iGb3 and 
naturally expressed ligands as determined in the present study. 
Here, we present two additional CD1d expression models to 
further test this hierarchy in vivo. In pLck/high mice express-
ing CD1d under the control of the proximal Lck promoter in 
a NOD.CD1d−/− background, the level of CD1d was 12 
times higher than that of WT mice (31). These Tg mice ex-
hibited a dramatic decrease in the proportion of Vβ7+ NKT 
cells from 21 to 12%, without signifi  cant changes in total cell 
numbers (Fig. 8). Although this Tg model was studied in the 
NOD background, which is known to be a low NKT ex-
pressor, the results were signifi  cant because they could be 
compared with littermate controls in the very same genetic 
background. Conversely, in C57BL/6 mice expressing a 
CD1d null allele and a CD1d low allele (an unintended con-
sequence of a loxP insertion in the 5′UTR of CD1d1 locus) 
(CD1d−/LE mice), the percentage of Vβ7 cells reached 43% 
as compared with 22% in WT controls, with a corresponding 
decrease of Vβ8 cells from 57 to 41% (Fig. 8). Overall, NKT 
cell numbers were drastically reduced, suggesting that in the 
presence of a limited amount of ligands, positive selection 
could only rescue the highest affi   nity cells. Thus, combining 
these two new models with the other two previously pub-
lished, the in vivo thymic selection outcomes are remarkably 
consistent with the Vβ hierarchy of affi   nity directly estab-
lished from our ligand stimulation assays.
V𝗃-specifi  c induction of CD69 upon intrathymic 
cell transfer
To further study the recognition of naturally expressed NKT 
ligands, we transferred Vβ nonbiased Vα14-Jα18 Tg DN T 
cells into the thymus of Ly5.1 congenic recipients. Cells were 
recovered from the host thymuses after 6 h and subjected to 
an analysis of Vβ and CD69 expression. In the absence of ex-
ogenous antigen, CD69 was induced on a subset of trans-
ferred cells with a selective Vβ7 (46%)>Vβ8 (43%)>Vβ2 
(38%) pattern (Fig. 9) reminiscent of iGb3 stimulation assays 
in vitro. Surprisingly, however, two additional Vβs, Vβ9 and 
Vβ14, exhibited signifi   cant induction of CD69, albeit to 
lower levels than the canonical Vβ7, Vβ8, Vβ2, suggesting 
weaker signaling. This surprising result was consistently ob-
served in 3/3 independent transfer experiments and may sug-
gest that, in addition to iGb3, other thymic ligands may be 
able to activate NKT precursors. These putative antigens, 
however, must be unable to meet the critical signaling re-
quirements for inducing cell expansion and/or survival. Un-
fortunately, the transferred Vα14-Jα18 Tg DN T cells could 
not be effi   ciently tracked over the longer period of time re-
quired to evaluate cell proliferation, precluding a more com-
plete assessment of the fate of these Vβ9 and Vβ14 cells.
D  I  S  C  U  S  S  I  O  N 
By transgenically expressing the Vα14-Jα18 transgene in a 
CD1d-defi  cient background, we have created a DN T cell 
population with a TCR repertoire made of the canonical in-
variant α chain of NKT cells combined with a broad, nonbi-
ased Vβ repertoire. Several features suggest that these Tg cells 
display a faithful representation of the preselection repertoire 
of TCR β chains associated with Vα14-Jα18 α chain. First, 
they originate in the thymus in the absence of selection by 
CD1d/ligand. Second, they express an endogenous TCR β 
Figure 8.  V𝗃 repertoire changes in mice expressing high or low 
levels of CD1d. (top) Levels of CD1d expression (mean fl  uorescence 
  intensity indicated above histograms) by thymocytes of indicated mice. 
CD1d−/LE are mice with a null (−) allele and a low expression (LE) allele 
the result of a loxP insertion in the 5′UTR of CD1d1. pLck/high are mice 
with high level expression of a CD1d transgene driven by the proximal Lck 
promoter. (bottom) Percentages of Vβ7 and Vβ8 cells among α-GalCer-
CD1d tetramer+ cells were determined by FACS analysis of indicated mice. 
Bars represent mean and SD (white, Vβ7; gray, Vβ8) based on indicated 
“n” number of mice examined. “CD1d =”: relative CD1d expression level 
(mean fl  uorescence intensity) compared with B6 WT mice; “NKT =”: rela-
tive numbers of NKT thymocytes compared with B6 WT mice. *, statistical 
signifi  cance (P < 0.05) using unpaired Student’s t test.JEM VOL. 203, May 15, 2006  1205
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repertoire of breadth and diversity comparable to that of 
nonselected DP thymocytes. Third, their ontogeny is related 
to the premature expression of the Tg TCR α chain that 
binds to the TCR β chains expressed at the DN3 stage. It is 
believed that, by modifying the signals that normally emanate 
from the pTα–TCRβ complexes, the TCR α transgene by-
passes the subsequent need for TCR-mediated positive selec-
tion (16–20, 32). Finally, similar to a subset of mature NKT 
cells, these Tg cells do not express CD4 or CD8. These Tg 
DN cells provide, therefore, a unique tool to explore the 
structure and the functional properties of the preselection 
repertoire of NKT precursor thymocytes and to contrast 
them with those of natural mature NKT cells.
Our fi  ndings elucidate some long-standing issues regard-
ing the mechanisms underlying NKT cell repertoire selec-
tion. Because the nonselected Vβ repertoire associated with 
Vα14-Jα18 diff  ered only slightly from the one found in the 
nonselected DP thymocytes of MHC-null mice, which rep-
resents an average of all Vαs, we conclude that the Vβ-pair-
ing bias of Vα14-Jα18 α chain must be modest compared 
with other Vαs. This fi  nding contrasts with isolated or indi-
rect evidence suggesting an inherent instability of many 
Vα14–Jα18/Vβ complexes (10, 11).
Second, by comparing the frequency of Vβ families in 
the unselected and postselection repertoire, it was possible for 
the fi  rst time to measure the degree of enrichment for indi-
vidual families, with Vβ7 (x12) clearly above Vβ8.2 (x8) and 
Vβ2 (x2.6) at the bottom. The picture would be signifi  cantly 
diff  erent if the baseline for comparison was the DP repertoire 
because Vβ7 and Vβ8.2 would appear to be equally selected 
(14). Remarkably, these data matched precisely the hierarchy 
of Vβ responses observed after stimulating the nonselected 
Vα14-Jα18 Tg T cells with naturally expressed ligands or 
with synthetic iGb3. Thus, we conclude that the Vβ reper-
toire associated with Vα14-Jα18 in NKT lineage cells has 
undergone predominant positive selection and only modest 
negative selection.
Importantly, the close resemblance between stimulation 
by iGb3 and stimulation by the naturally expressed NKT lig-
ands provides new and independent support for the notion 
that iGb3 is the main NKT ligand involved in these thymic 
processes. A large proportion ranging from 20 to 50% of the 
Vβ8-, Vβ7-, and Vβ2-expressing cells responded to iGb3 in 
the CD69 induction assay, whereas nearly all of them re-
sponded in the CFSE dilution assay. Although the diff  erent 
nature and kinetics of these assays may underlie these diff  er-
ences, the results converge to indicate that a substantial pro-
portion of the naturally arising Vβ8, Vβ7, and Vβ2 TCRs 
may be selected during NKT cell development. Surprisingly, 
Vβ9- and Vβ14-expressing cells consistently exhibited some 
level of CD69 induction upon intrathymic transfer, despite 
the absence of response to iGb3 and despite the absence of 
corresponding cells in the natural NKT cell pool. This obser-
vation could indicate that additional unidentifi  ed ligands par-
tially activate NKT precursors during thymic development, 
yet may not promote their selection or expansion, perhaps as 
a result of lower affi   nity.
Another important insight gained from this study relates 
to the much larger repertoire elicited by synthetic α-GalCer, 
a mimic of microbial glycuronosylceramides, than by endog-
enous ligands. Thus, many Vβs that are not stimulated by 
iGb3 and are not found in the natural NKT repertoire, in-
cluding Vβ3, 6, 9, 10, 14, could nevertheless be stimulated 
by nanomolar concentrations of α-GalCer. These unex-
pected fi  ndings demonstrate that the NKT cell repertoire 
against foreign and microbial antigens is severely limited be-
cause thymic exposure to natural ligands failed to select po-
tentially useful TCRs. This stands in sharp contrast with 
positive selection driven by polymorphic MHC ligands, 
where the opposite outcome is observed, namely a gain in 
recognition of foreign peptides after positive selection by 
self-ligands (33). We propose that these diff  erences may be 
inherent to the processes of positive selection by partial ago-
nists/antagonists versus full agonists.
Finally, our results directly confi  rm and extend to the 
entire nonselected repertoire recent reports (14) suggesting 
that diff  erent Vβ families generically encode diff  erent affi   n-
ities for lipid ligands. Vβ7 responded much better than 
Vβ8.2 to low doses of natural ligand, whereas both re-
sponded comparably to α-GalCer and microbial ligands. Be-
cause of the absence of CDR3 restriction in these responses, 
the CDR1 and 2 regions of the β chain may confer the dif-
ferences in affi   nity. Future structural studies of these interac-
tions, including crystallography and mutational analysis, will 
Figure 9.  V𝗃-specifi  c induction of CD69 after intrathymic 
transfer of V𝗂14tg.CD1d−/− DN T cells. DN T cells were intrathy-
mically injected into Ly5.1 congenic host. After 6 h, CD69 expres-
sion was determined by FACS analysis of Ly5.2+CD4−CD8α−-gated 
cells according to Vβ expression. Data are means ± SD from three 
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shed light on this intriguing mode of TCR recognition. In 
the meantime, our quantitative determination of the hierar-
chy of natural   ligand recognition by diff  erent Vβ families 
provides potentially useful knowledge to assess the contribu-
tion of affi   nity to the functional properties of NKT cell sub-
sets and to the selection of NKT cells in mice exhibiting 
NKT cell defects.
MATERIALS AND METHODS
Mice. C57BL/6 and NOD mice were purchased from The Jackson Labora-
tory. C57BL/6.β2M−/−.I-Ab−/− (MHC-null) and C57BL/6.Ly5.1 congenic 
mice were purchased from Taconic Farm. C57BL/6.Vα14tg and C57BL/6.
CD1d−/− mice were described previously (15, 34), and were intercrossed to 
obtain C57BL/6.Vα14tg.CD1d−/− mice. The CD1dLE (LE, low expression) 
allele was the unintended consequence of the insertion of a loxP site in the 
5′UTR of the C57BL/6 CD1d1 gene after homologous recombination in 
ES cell and excision of a neomycinr gene and a STOP sequence cassette. This 
insertion resulted in the modifi  cation of the genomic sequence upstream 
of the ATG site, 5′-T  A  G  A  A  C  T  C  T  G  G  C  G  ^CTATG-3′, which included 
a deletion of the underlined GCG and an insertion at the position marked 
^ of the sequence 5′-C  A  T  A  A  C  T  T  C  G  T  A  T  A  G  C  A  T  A  C  A  T  T  A  T  A  C  G  A  A-
G  T  T  A  T  A  T  T  A  A  G  G  G  T  T  A  T  T  G  A  A  T  A  T  G  A  T  C  G  G  A  A  T  T  C  C  T  C  G  A  G  C-
G  G  C  -3′. The C57BL/6.CD1d−/LE mouse carrying a null allele and a LE 
allele expressed very reduced levels of CD1d on the surface of thymocytes. 
The LE allele was screened using PCR (forward primer: 5′-T  G  T  G  T  A  G-
A  A  C  T  C  T  G  C  A  T  A  A  C  T  T  C  G  -3′, reverse primer: 5′-G  G  G  C  C  A  G  G  T  G  T  A-
T  T  C  A  G  G  A  G  C  A  T  C  T  G  C  A  C  G  G  -3′). All mice were housed in a specifi  c 
pathogen-free facility at the University of Chicago according to the guide-
lines of the institutional animal care and use committee.
Flow cytometry. Fluorochrome-conjugated mAbs anti-CD1d, CD3ε, 
CD4, CD8α, CD44, CD69, Ly5.2, NK1.1, TCRβ, TCR Vβ2 through 
Vβ14, TCR Vα2, Vα3.2, Vα8.3, and Vα11.1+11.2, as well as biotinylated 
Vβ2 through Vβ14 mAbs, were purchased from BD Biosciences. Streptavi-
din conjugated to allophycocyanin (APC) or R-PE was purchased from 
eBioscience. Anti-Vβ8.2 mAb (clone F23.2) was biotinylated in our labora-
tory. CD1d tetramers loaded with α-GalCer were prepared and used as 
  described previously (23). CFSE labeling of enriched splenocytes was done 
in vitro according to manufacturer’s instructions in CellTrace CFSE Cell 
Proliferation kit (Invitrogen). Flow cytometry analysis was performed on a 
four-color FACSCalibur with CELLQuest software (BD Biosciences).
CDR3 sequencing. DN T cells were sorted as TCRβ+CD4−CD8α− cells 
from C57BL6.Vα14tg.CD1d−/− splenocytes. RNA extraction, reverse tran-
scription PCR, and plasmid cloning and sequencing methods were as described 
previously (35). Primers were 5′-C  C  T  C  A  T  T  C  T  G  G  A  G  T  T  G  G  C  T  A  C  C  C  -3′ 
for Vβ8.2+8.1, 5′-G  A  A  G  A  T  G  G  T  G  G  G  G  C  T  T  T  C  A  A  G  G  A  T  C  -3′ for Vβ12, 
and 5′-C  T  T  G  G  G  T  G  G  A  G  T  C  A  C  A  T  T  T  C  T  C  -3′ for Cβ. CDR3 sequence 
analyses were performed according to the international ImMunoGeneTics 
(IMGT) information system website (http://imgt.cines.fr) (36).
Cell stimulation assays. Single cell suspensions prepared from four to fi  ve 
adult C57BL6.Vα14tg.CD1d−/− spleens were fi  rst enriched for DN T cells 
by depleting B, CD4, CD8, and NK cells with B220, CD4, CD8α, and 
DX5 mAb-conjugated magnetic microbeads and AutoMACS (Miltenyi 
Biotec) according to manufacturer’s instructions. DX5 is not expressed by 
the DN T cells. For the CFSE expansion assay, this enriched population 
(>50% were DN CD3ε+ cells) was labeled with CFSE before stimulation 
with lipid-pulsed BM-DCs. The DCs were prepared from cultures of BM 
cells in a 1:1 mixture of EHAA and RPMI 1640 (Biofl  uids) supplemented 
with 10% heat-inactivated fetal calf serum, glutamine, antibiotics, 5 × 10−5 M 
of 2-mercaptoethanol and 2 ng/ml of mouse GM-CSF (Biosource). After 
6 d of culture, BM-DCs were pulsed with diff   erent concentrations of 
α-GalCer or iGb3 overnight, washed, and plated at 106 per well in six-well 
plates (Corning Costar). 10 × 106 enriched DN T cells were added per well 
and cultured in the presence of mouse recombinant IL-7 at 10 ng/ml (Bio-
source) for 4 d before FACS analysis. For the CD69 induction assay, the 
lipid-pulsed DCs were allowed to adhere to culture wells for 16–24 h before 
adding the enriched DN T cells. These cocultures were spun down briefl  y 
(1,200 revolutions/min) to favor cell-to-cell contact. After 4–6 h, the DN T 
cells were harvested and processed for FACS analysis, using anti-CD69, Vβs, 
CD3ε, and CD4 and CD8α antibodies.
Intrathymic cell transfers. DN T cells enriched from C57BL/6.Vα14tg.
CD1d−/− spleens (Ly5.2) by depleting B, CD4, CD8, and NK cells with 
B220, CD4, CD8α, and DX5 mAb-conjugated magnetic microbeads and 
AutoMACS were injected intrathymically into C57BL6.Ly5.1 congenic 
hosts as described previously (37). After 6 h, thymocytes were harvested 
and depleted of CD4- and CD8α-expressing cells using magnetic micro-
beads and AutoMACS (Miltenyi Biotec) before FACS analysis. Transferred 
DN T cells cells were identifi  ed using anti-Ly5.2, CD69, Vβs, and CD4 
and CD8α antibodies.
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